Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-30
DOI
10.1038/s41598-019-56336-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Host and parasite responses in human diffuse cutaneous leishmaniasis caused by L. amazonensis
- (2019) Stephen M. Christensen et al. PLoS Neglected Tropical Diseases
- PDL-1 Blockade Prevents T Cell Exhaustion, Inhibits Autophagy, and Promotes Clearance of Leishmania donovani
- (2018) Samar Habib et al. INFECTION AND IMMUNITY
- Next generation of immune checkpoint therapy in cancer: new developments and challenges
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by Leishmania (L.) amazonensis
- (2018) Daniel Holanda Barroso et al. Frontiers in Immunology
- Immunomodulating role of IL-10-producing B cells in Leishmania amazonensis infection
- (2018) Luan Firmino-Cruz et al. CELLULAR IMMUNOLOGY
- Pharmacokinetic drug evaluation of atezolizumab for the treatment of locally advanced or metastatic urothelial carcinoma
- (2017) Rutveej Patel et al. Expert Opinion on Drug Metabolism & Toxicology
- Tumor-Infiltrating T Cells and the PD-1 Checkpoint Pathway in Advanced Differentiated and Anaplastic Thyroid Cancer
- (2016) Jill J. Bastman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A meta-analysis of efficacy and safety of antibodies targeting PD-1/PD-L1 in treatment of advanced nonsmall cell lung cancer
- (2016) Cuihua Wang et al. MEDICINE
- Subset- and Antigen-Specific Effects of Treg on CD8+ T Cell Responses in Chronic HIV Infection
- (2016) Maria Nikolova et al. PLoS Pathogens
- PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
- (2015) Kevin C. Soares et al. JOURNAL OF IMMUNOTHERAPY
- IFN-γ-Dependent Recruitment of CD4+T Cells and Macrophages Contributes to Pathogenesis DuringLeishmania amazonensisInfection
- (2015) Matheus Batista Heitor Carneiro et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Blockade of PD-1/PD-L1 Promotes Adoptive T-Cell Immunotherapy in a Tolerogenic Environment
- (2015) Stephen J. P. Blake et al. PLoS One
- Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells
- (2014) Shasha Song et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Parasite-Derived Arginase Influences Secondary Anti-Leishmania Immunity by Regulating Programmed Cell Death-1-Mediated CD4+ T Cell Exhaustion
- (2013) Z. Mou et al. JOURNAL OF IMMUNOLOGY
- Programmed Death 1-Mediated T Cell Exhaustion during Visceral Leishmaniasis Impairs Phagocyte Function
- (2013) K. J. Esch et al. JOURNAL OF IMMUNOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection
- (2012) Gaia Nebbia et al. PLoS One
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin – than on footpad-infected mice
- (2011) Tania C. Felizardo et al. EXPERIMENTAL PARASITOLOGY
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade
- (2011) R. Bhadra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- CD8 Cells of Patients with Diffuse Cutaneous Leishmaniasis Display Functional Exhaustion: The Latter Is Reversed, In Vitro, by TLR2 Agonists
- (2010) Joselín Hernández-Ruiz et al. PLoS Neglected Tropical Diseases
- Immunologic Indicators of Clinical Progression during Canine Leishmania infantum Infection
- (2009) P. M. Boggiatto et al. Clinical and Vaccine Immunology
- Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?
- (2009) L. R. Guerin et al. HUMAN REPRODUCTION UPDATE
- PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cells
- (2009) Wenshi Wang et al. INTERNATIONAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now